Section 13. Short-Course Pretransplant Antiviral Therapy is a Feasible and Effective Strategy to Prevent Hepatitis C Recurrence After Liver Transplantation in Genotype 2 Patients-Reference-Cited by-同舟云学术

Section 13. Short-Course Pretransplant Antiviral Therapy is a Feasible and Effective Strategy to Prevent Hepatitis C Recurrence After Liver Transplantation in Genotype 2 Patients

Published:2014-04-27 Issue:Supplement 8S Volume:97 Page:S47-S53
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Lin Chih-Che,Kabiling Catherine,Chen Chao-Long,Lin Yu-Hung,Liu Yueh-Wei,Wang Chih-Chi,Hu Tsung-Hui,Chiu King-Wah

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference18 articles.

1. Hepatitis C virus kinetics during and immediately after liver transplantation.;Garcia-Retortillo;Hepatology,2002

2. Recurrent and acquired hepatitis C viral infection in liver transplant recipients.;Wright;Gastroenterology,1992

3. Incidence, prevalence, and clinical course of hepatitis C following liver transplantation.;Shah;Gastroenterology,1992

5. Report of the monothematic EASL conference on liver transplantation for viral hepatitis (Paris, France, January 12-14, 2006).;Samuel;J Hepatol,2006

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of IL28B SNPs rs12979860 and rs8099917 on Hepatitis C Virus-RNA Status in Donors/Recipients of Living Donor Liver Transplantation;PLOS ONE;2016-06-08

2. Living Donor Liver Transplantation;Transplantation;2016-06

3. Treatment of Recurrent Hepatitis C;Disease Recurrence After Liver Transplantation;2016

4. Hepatitis C: New challenges in liver transplantation;World Journal of Gastroenterology;2015-05-21